Literature DB >> 25257737

Treatment of subarachnoid hemorrhage.

Amanda K Raya1, Michael N Diringer2.   

Abstract

Nontraumatic subarachnoid hemorrhage from intracranial aneurysm rupture presents with sudden severe headache. Initial treatment focuses on airway management, blood pressure control, and extraventricular drain for hydrocephalus. After identifying the aneurysm, they may be clipped surgically or endovascularly coiled. Nimodipine is administered to maintain a euvolemic state and prevent delayed cerebral ischemia (DCI). Patients may receive anticonvulsants. Monitoring includes serial neurologic assessments, transcranial Doppler ultrasonography, computed tomography perfusion, and angiographic studies. Treatment includes augmentation of blood pressure and cardiac output, cerebral angioplasty, and intra-arterial infusions of vasodilators. Although early mortality is high, about one half of survivors recover with little disability.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aneurysm; Delayed cerebral ischemia; Subarachnoid hemorrhage; Transcranial Doppler ultrasonography; Vasospasm

Mesh:

Substances:

Year:  2014        PMID: 25257737     DOI: 10.1016/j.ccc.2014.06.004

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  10 in total

1.  Blood Pressure Management in Intracranial Hemorrhage: Current Challenges and Opportunities.

Authors:  Cheryl Carcel; Shoichiro Sato; Craig S Anderson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-04

2.  Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.

Authors:  Monisha Kumar; Wenjing Cao; Jenny K McDaniel; Huy P Pham; Dheeraj Raju; Kelsey Nawalinski; Suzanne Frangos; David Kung; Eric Zager; Scott E Kasner; Joshua M Levine; X Long Zheng
Journal:  Thromb Haemost       Date:  2017-01-19       Impact factor: 5.249

Review 3.  Interventions for altering blood pressure in people with acute subarachnoid haemorrhage.

Authors:  Mathias Maagaard; William K Karlsson; Christian Ovesen; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-11-17

Review 4.  Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: Beyond Vasospasm and Towards a Multifactorial Pathophysiology.

Authors:  Joseph R Geraghty; Fernando D Testai
Journal:  Curr Atheroscler Rep       Date:  2017-10-23       Impact factor: 5.113

Review 5.  Aneurysmal Subarachnoid Hemorrhage.

Authors:  David Y Chung; Mohamad Abdalkader; Thanh N Nguyen
Journal:  Neurol Clin       Date:  2021-03-31       Impact factor: 3.806

Review 6.  Polymorphisms of apolipoprotein E and aneurysmal subarachnoid haemorrhage: A meta-analysis.

Authors:  S Arati; M K Sibin; Dhananjaya I Bhat; K V L Narasingarao; G K Chetan
Journal:  Meta Gene       Date:  2016-06-17

Review 7.  Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage.

Authors:  Won-Sang Cho; Jeong Eun Kim; Sukh Que Park; Jun Kyeung Ko; Dae-Won Kim; Jung Cheol Park; Je Young Yeon; Seung Young Chung; Joonho Chung; Sung-Pil Joo; Gyojun Hwang; Deog Young Kim; Won Hyuk Chang; Kyu-Sun Choi; Sung Ho Lee; Seung Hun Sheen; Hyun-Seung Kang; Byung Moon Kim; Hee-Joon Bae; Chang Wan Oh; Hyeon Seon Park
Journal:  J Korean Neurosurg Soc       Date:  2018-02-28

8.  mRNA Expression Profiles from Whole Blood Associated with Vasospasm in Patients with Subarachnoid Hemorrhage.

Authors:  Huichun Xu; Boryana Stamova; Bradley P Ander; Ben Waldau; Glen C Jickling; Frank R Sharp; Nerissa U Ko
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.210

Review 9.  The Role of Thromboinflammation in Delayed Cerebral Ischemia after Subarachnoid Hemorrhage.

Authors:  Devin W McBride; Spiros L Blackburn; Kumar T Peeyush; Kanako Matsumura; John H Zhang
Journal:  Front Neurol       Date:  2017-10-23       Impact factor: 4.003

10.  Herbal medicines for the prevention and treatment of cerebral vasospasm after subarachnoid hemorrhage: A protocol for systematic review and meta-analysis.

Authors:  Yuna Seo; Han-Gyul Lee; Chul Jin; Seung-Bo Yang; Seung-Yeon Cho; Seong-Uk Park; Woo-Sang Jung; Sang-Kwan Moon; Jung-Mi Park; Chang-Nam Ko; Ki-Ho Cho; Seungwon Kwon
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.